NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Predictions

etoro logo Buy CATB
*Your capital is at risk
$3.36
+0.195 (+6.16%)
At Close: May 27, 2022
Currently predicting for Mon, 8 Jun 2026

CATB Prediction Chart

CATB Predictions History

Latest community submissions for CATB.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Feb 1, 2021 $3.85 +5.77% $3.64 X 94.23% 1
Natacha Gaymer-Jones Natacha Gaymer-Jones @NatachaGaymer-Jones.194439
Feb 1, 2021 Bullish $3.64 X 0
JS JS Pro
Oct 27, 2020 $5.46 +250.00% Unrealistic Excluded from avg $1.56 X 0.00% 0
DeMichael Franklin DeMichael Franklin @DeMichaelFranklin.171886
Oct 27, 2020 $1.50 -3.85% $1.56 X 96.15% 1
JS JS Pro
Jan 17, 2020 Bullish $7.00 X 0
2poJeff 2poJeff Pro
Jan 17, 2020 $6.88 -1.71% $7.00 X 98.29% 1
Jan 17, 2020 $6.79 -3.00% $7.00 X 97.00% 0
Jan 25, 2019 $6.34 +2.59% $6.18 X 97.40% 0
Sep 19, 2017 $1.50 -9.64% $1.66 X 90.40% 0
JS JS Pro
Sep 15, 2017 $1.65 -2.37% $1.69 X 97.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CATB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CATABASIS PHARMACEUTICALS
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE